These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30759833)

  • 1. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.
    Hajialyani M; Hosein Farzaei M; Echeverría J; Nabavi SM; Uriarte E; Sobarzo-Sánchez E
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential and Clinical Evidence of Hesperidin as Neuroprotective Agent.
    Joshi S; Dhingra AK; Chopra B; Guarve K; Bhateja D
    Cent Nerv Syst Agents Med Chem; 2022; 22(1):5-14. PubMed ID: 35379141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect.
    Li X; Huang W; Tan R; Xu C; Chen X; Li S; Liu Y; Qiu H; Cao H; Cheng Q
    Biomed Pharmacother; 2023 Mar; 159():114222. PubMed ID: 36628819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review.
    Bansal K; Singh V; Singh S; Mishra S
    Curr Mol Med; 2024; 24(3):316-326. PubMed ID: 36959141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases.
    Evans JA; Mendonca P; Soliman KFA
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hesperidin: A Therapeutic Agent For Obesity.
    Xiong H; Wang J; Ran Q; Lou G; Peng C; Gan Q; Hu J; Sun J; Yao R; Huang Q
    Drug Des Devel Ther; 2019; 13():3855-3866. PubMed ID: 32009777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
    Frandsen JR; Narayanasamy P
    Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation.
    Rainey-Smith S; Schroetke LW; Bahia P; Fahmi A; Skilton R; Spencer JP; Rice-Evans C; Rattray M; Williams RJ
    Neurosci Lett; 2008 Jun; 438(1):29-33. PubMed ID: 18467030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin for neurodegenerative diseases: a review.
    Jayawickreme DK; Ekwosi C; Anand A; Andres-Mach M; Wlaź P; Socała K
    Pharmacol Rep; 2024 Aug; 76(4):644-664. PubMed ID: 38904713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer's disease.
    Justin Thenmozhi A; William Raja TR; Manivasagam T; Janakiraman U; Essa MM
    Nutr Neurosci; 2017 Jul; 20(6):360-368. PubMed ID: 26878879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats.
    Menze ET; Tadros MG; Abdel-Tawab AM; Khalifa AE
    Neurotoxicology; 2012 Oct; 33(5):1265-75. PubMed ID: 22850463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Phenolic Compounds with Neuroprotective Effects.
    Tavan M; Hanachi P; de la Luz Cádiz-Gurrea M; Segura Carretero A; Mirjalili MH
    Neurochem Res; 2024 Feb; 49(2):306-326. PubMed ID: 37940760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid.
    Tóth F; Cseh EK; Vécsei L
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders.
    Sethiya NK; Ghiloria N; Srivastav A; Bisht D; Chaudhary SK; Walia V; Alam MS
    CNS Neurol Disord Drug Targets; 2024; 23(7):865-882. PubMed ID: 37461364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic review of the anticancer potential of hesperidin, a natural flavonoid from citrus fruits.
    Pandey P; Khan F
    Nutr Res; 2021 Aug; 92():21-31. PubMed ID: 34273640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoid-based therapies in the early management of neurodegenerative diseases.
    Solanki I; Parihar P; Mansuri ML; Parihar MS
    Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.